Literature DB >> 15224446

Assessing preferences for schizophrenia outcomes: comprehension and decision strategies in three assessment methods.

Martha Shumway1, Tetine Sentell, Tandy Chouljian, Jen Tellier, Francine Rozewicz, Michele Okun.   

Abstract

Quantifying the importance of treatment outcomes by measuring preferences allows construction of aggregate outcome indicators that reflect the relative importance of multiple outcomes, trade-offs between outcomes, and the perspectives of different stakeholders. However, standard preference assessment methods are cognitively complex and may be particularly challenging for persons with schizophrenia and other serious mental illnesses. Preferences may not be meaningful or comparable across stakeholder groups if the groups do not use the methods in similar ways. This study combined qualiative and quantitative methods to compare comprehension and decision strategies across three standard preference assessment methods (Rating Scale, Time Tradeoff, and Paired Comparison) in 2 stakeholder groups (consumers of schizophrenia treatment and clinicians). Results indicate that the Rating Scale method is likely to yield the most valid and comparable preference values because it is well understood and acceptable to both consumers and clinicians. Both groups found the Time Tradeoff method difficult to use and poorly suited to evaluating schizophrenia outcomes.

Entities:  

Mesh:

Year:  2003        PMID: 15224446     DOI: 10.1023/a:1024415001045

Source DB:  PubMed          Journal:  Ment Health Serv Res        ISSN: 1522-3434


  6 in total

1.  Measuring preferences for schizophrenia outcomes with the time tradeoff method.

Authors:  Martha Shumway; Tandy L Chouljian; Cynthia L Battle
Journal:  J Behav Health Serv Res       Date:  2005 Jan-Mar       Impact factor: 1.505

Review 2.  What matters to patients? A systematic review of preferences for medication-associated outcomes in mental disorders.

Authors:  Øystein Eiring; Brynjar Fowels Landmark; Endre Aas; Glenn Salkeld; Magne Nylenna; Kari Nytrøen
Journal:  BMJ Open       Date:  2015-04-08       Impact factor: 2.692

3.  Physician and patient benefit-risk preferences from two randomized long-acting injectable antipsychotic trials.

Authors:  Eva G Katz; Brett Hauber; Srihari Gopal; Angie Fairchild; Amy Pugh; Rachel B Weinstein; Bennett S Levitan
Journal:  Patient Prefer Adherence       Date:  2016-10-21       Impact factor: 2.711

4.  Socioemotional mechanisms of loneliness in subclinical psychosis.

Authors:  Logan D Leathem; Danielle L Currin; Amanda K Montoya; Katherine H Karlsgodt
Journal:  Schizophr Res       Date:  2021-10-20       Impact factor: 4.939

5.  Developing a discrete choice experiment in Malawi: eliciting preferences for breast cancer early detection services.

Authors:  Racquel E Kohler; Clara N Lee; Satish Gopal; Bryce B Reeve; Bryan J Weiner; Stephanie B Wheeler
Journal:  Patient Prefer Adherence       Date:  2015-10-14       Impact factor: 2.711

6.  Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional study.

Authors:  Kie Takahashi; Ryoko Yamazawa; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida
Journal:  Neuropsychopharmacol Rep       Date:  2020-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.